Medical News

RSS

Report examines effects of traumatic events on mental health status of adults in Central African Republic

More than three-quarters of adults in the Central African Republic report witnessing or personally experiencing traumatic events during the most recent wave of violence, and more than half meet criteria for depression or anxiety, according to a report in the August 4 issue of JAMA, a theme issue on violence and human rights.

4 Aug 2010

drugstore.com announces extension of strategic alliance with Medco Health Solutions

drugstore.com, inc., a leading online retailer of health, beauty, vision, and pharmacy products, today announced the extension through 2018 of its strategic alliance with Medco Health Solutions, Inc., one of the nation's leading healthcare companies.

4 Aug 2010

Bill Gates to keynote at 2010 mHealth Summit

Bill Gates, Co-Chair and Trustee of the Bill & Melinda Gates Foundation, will provide a keynote address on the opportunity of mobile technologies to improve health outcomes in the developing world at the 2010 mHealth Summit, the summit organizers announced today. The summit, organized by the Foundation for the National Institutes of Health in partnership with the National Institutes of Health (NIH) and the mHealth Alliance, will be held November 8-10 in Washington, DC.

4 Aug 2010

GenSpera acquires patent application for medical imaging technology

GenSpera, Inc. announced that it has acquired a patent application from the Johns Hopkins University and the University of Copenhagen for technology relating to medical imaging. The technology incorporates derivatives of thapsigargin, the active ingredient in GenSpera's therapeutics program, coupled with its patented tumor-targeted peptides, to create cancer-specific imaging compounds.

4 Aug 2010

Savient second-quarter net loss decreases to $5.0 million

Savient Pharmaceuticals, Inc. reported financial results for the three and six months ended June 30, 2010. The net loss for the second quarter of 2010 was $5.0 million, or $0.07 per basic and diluted share, on total revenues of $1.0 million, compared with a net loss of $54.8 million, or $0.92 per basic and diluted share on total revenues of $0.7 million for the second quarter of 2009.

4 Aug 2010

Invivo recognized with 2010 Gold Medical Design Excellence Award

On June 9, 2010, Invivo was recognized with a 2010 Gold Medical Design Excellence Award for its DynaCAD for Prostate and DynaTRIM (Trans-Rectal Interventional MRI) clinical solutions. The MDEA awards ceremony took place in early June at New York City's Jacob K. Javits Convention Center where gold and silver winners were honored.

4 Aug 2010

MabCure files provisional patent application for ovarian cancer diagnostic antibodies

Biotechnology company MabCure, Inc. today announced the company has filed a provisional patent application for its ovarian cancer diagnostic antibodies with the U.S. Patent and Trademark Office. The filing was based on positive results of a recent study that showed MabCure's tumor-specific monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent) and distinguished it from benign tumors of the ovaries or healthy blood obtained from men and women.

4 Aug 2010

Definiens launches Tissue Studio 2.0 image analysis software for digital pathology

Definiens today announced the introduction of Definiens Tissue Studio™ 2.0, the latest version of the company's leading image analysis software for digital pathology.

4 Aug 2010

MOM Project increases access to maternal health care services for internally displaced woman

A community-based maternal health delivery strategy known as the MOM Project dramatically increased access to maternal health care services for internally displaced woman in eastern Burma, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. Among the findings, the study showed a ten-fold increase in the proportion of women assisted at delivery by workers skilled in providing emergency obstetric care, including preventing and treating hemorrhage, injectable antibiotics and anticonvulsants, and community-based blood transfusion.

4 Aug 2010

STAAR Surgical second-quarter total net revenue increases 3.7% to $13.6 million

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported results for the second quarter ended July 2, 2010. Revenue for the period grew 3.7% to $13.6 million with the revenue from core products, IOLs and ICLs, increasing by 7%. For the first half of 2010 core product revenues increased by 11% reflecting market share gains by STAAR.

4 Aug 2010

IL releases new HemosIL HIT-Ab(PF4-H) assay

Instrumentation Laboratory (IL) today announced the release of the new HemosIL HIT-Ab(PF4-H) assay as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. Delivering results in minutes, the HemosIL HIT-Ab(PF4-H) assay detects total immunoglobulin against Platelet Factor 4-Heparin complexes, the antibodies associated with the pathology of HIT.

4 Aug 2010

NYT: Rep. Ryan's 'sweeping agenda' includes revising Medicare

The New York Times profiles Rep. Paul Ryan, R-Wis., and details the rising Republican star's positions on health care and social programs, among other things. Under his controversial "Roadmap for America's Future" plan, Ryan would eliminate the federal debt over 50 years through major changes to Medicare and Social Security.

4 Aug 2010

Contrave added to diet and exercise regimen can induce significant weight loss

Orexigen Therapeutics, Inc. announced the online publication of results from its COR-BMOD trial of Contrave (naltrexone SR/bupropion SR) in the journal Obesity. The COR-BMOD trial evaluated intensive behavior modification plus Contrave32 (32mg naltrexone sustained release (SR)/360mg bupropion SR) compared to BMOD plus placebo, in 793 overweight or obese patients.

4 Aug 2010

Matrixx Initiatives first-quarter net loss reduces to $2.4 million

Matrixx Initiatives, Inc., an over-the-counter healthcare company that develops and markets Zicam® products, today announced financial results for its fiscal first quarter ended June 30, 2010.

4 Aug 2010

Solta Medical second-quarter 2010 revenue increases 10% to $30.1 million

Solta Medical, Inc., a global leader in the medical aesthetics market, today announced results for the second quarter ended June 30, 2010. The results for the quarter were highlighted by year-over-over revenue growth of 10%, generation of $7.7 million in cash flow from operations, and complete integration of the Aesthera acquisition into Solta operations.

4 Aug 2010

Bayer implements ValGenesis validation process management software at Berkeley and Emeryville sites

ValGenesis, Inc., a world-leading provider of Validation Lifecycle Management (VLM) software solutions, today announced that Bayer HealthCare AG has implemented ValGenesis software as their platform for validation process management at their Berkeley and Emeryville sites.

4 Aug 2010

Sunridge signs distribution agreement with Ameco Medical Equipment

Sunridge International announced today that it has signed an agreement with Ameco Medical Equipment L.L.C. for distribution rights in several Middle Eastern countries. The five-year contract valued at over 6.5 million dollars will start immediately.

4 Aug 2010

Special issue on new developments in vestibular rehabilitation

Rehabilitation is essential for patients with disabling symptoms of dizziness, vertigo, and unsteadiness caused by disorders of the vestibular system. A special issue of The Journal of Neurologic Physical Therapy (JNPT) presents an update on new and emerging vestibular rehabilitation techniques, highlighting the physical therapist's role on the multidisciplinary teams providing patient care and research.

4 Aug 2010

Ties between global health, national security, jobs emphasized at recent meeting in Washington State

The message that U.S. investment in global health "helps advance longer term security and development goals" while also supporting a "small but growing industry with good paying jobs and world class research" was the focus of a recent meeting between officials from Washington, D.C. and Washington State, the Seattle Times' "Business of Giving" blog writes.

4 Aug 2010

Achievement of tenth milestone triggers EUR 2.5 million payment from Boehringer Ingelheim to Evotec

Evotec AG today announced that its research alliance with Boehringer Ingelheim has reached a milestone, triggering a payment of EUR 2.5 million to Evotec. The milestone reached was the selection of a candidate compound for pre-development studies in an inflammation and immunology programme.

4 Aug 2010

Medical News

Report examines effects of traumatic events on mental health status of adults in Central African Republic

drugstore.com announces extension of strategic alliance with Medco Health Solutions

Bill Gates to keynote at 2010 mHealth Summit

GenSpera acquires patent application for medical imaging technology

Savient second-quarter net loss decreases to $5.0 million

Invivo recognized with 2010 Gold Medical Design Excellence Award

MabCure files provisional patent application for ovarian cancer diagnostic antibodies

Definiens launches Tissue Studio 2.0 image analysis software for digital pathology

MOM Project increases access to maternal health care services for internally displaced woman

STAAR Surgical second-quarter total net revenue increases 3.7% to $13.6 million

IL releases new HemosIL HIT-Ab(PF4-H) assay

NYT: Rep. Ryan's 'sweeping agenda' includes revising Medicare

Contrave added to diet and exercise regimen can induce significant weight loss

Matrixx Initiatives first-quarter net loss reduces to $2.4 million

Solta Medical second-quarter 2010 revenue increases 10% to $30.1 million

Bayer implements ValGenesis validation process management software at Berkeley and Emeryville sites

Sunridge signs distribution agreement with Ameco Medical Equipment

Special issue on new developments in vestibular rehabilitation

Ties between global health, national security, jobs emphasized at recent meeting in Washington State

Achievement of tenth milestone triggers EUR 2.5 million payment from Boehringer Ingelheim to Evotec

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News